Short Peptides Regulate Gene Expression
Computer modeling · 2016
- What was studied
- Docking models of 19 short peptides interacting with DNA
- Main finding
- Constructs DNA–peptide models, including AED and KE, to explore sequence-dependent binding and gene-regulation hypotheses.
Study data at a glance
- Participants or experimental model
- Docking models of 19 short peptides interacting with DNA
- Reported results
- Constructs DNA–peptide models, including AED and KE, to explore sequence-dependent binding and gene-regulation hypotheses.
Study limitations and source details
Study limitations
- Docking predictions are not clinical efficacy or demonstrated delivery to human tissues.
- Other peptides in the panel require sequence-specific mapping before attribution.
Source details
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Sources checked
Citation
Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology
Khavinson VK, Lin'kova NS, Tarnovskaya SI. Short Peptides Regulate Gene Expression Bull Exp Biol Med 162(2):288-292. PMID 27909961
Study source ↗ · DOI 10.1007/s10517-016-3596-7 · Bibliography entry · Link to this summary
Related compounds
Cartalax
A synthetic tripeptide, Ala–Glu–Asp (AED, also called T-31), studied in cartilage, bone and joint research. Some related experiments used a cartilage extract containing AED.
Vilon
A synthetic two-amino-acid peptide (Lys–Glu, or KE) studied in thymus, immune and tissue-repair research.